Segment Information

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Segment Information

Segment Information Management has concluded that: Life Sciences, which is focused on growth in the medical end market, primarily in the orthopaedics and medical/surgical end markets; Mobile Solutions, which is focused on growth in the general industrial and

automotive end markets; and Power Solutions, which is focused on growth in the electrical and aerospace and defense end markets, constitute our operating segments. Life Sciences, Mobile Solutions, and Power Solutions are considered operating segments as each engages in business activities for which it earns revenues and incurs expenses, discrete financial information is available for each, and this is the level at which the chief operating decision maker reviews discrete financial information for purposes of allocating resources and assessing performance.

The following tables present results of operations by reportable segment.

	Life Sciences		Mobile Solutions		Power Solutions		Corporate and Consolidations			Total
Three Months Ended June 30, 2020
Net sales	$	72,399	$	41,037	$	37,491	$	(507)	(a)	$	150,420
Income (loss) from operations	4,333		(4,592)		1,454		(9,401)			$	(8,206)
Interest expense										(18,696)
Other										881
Loss before benefit for income taxes and share of net loss from joint venture										$	(26,021)
Three Months Ended June 30, 2019
Net sales	$	91,332	$	79,444	$	51,393	$	(503)	(a)	$	221,666
Income (loss) from operations	9,305		3,506		5,682		(10,981)			$	7,512
Interest expense										(13,958)
Other										(57)
Loss before provision for income taxes and share of net income from joint venture										$	(6,503)

	Life Sciences		Mobile Solutions		Power Solutions		Corporate and Consolidations			Total
Six Months Ended June 30, 2020
Net sales	$	156,447	$	110,921	$	83,892	$	(1,095)	(a)	$	350,165
Goodwill impairment	146,757		—		92,942		—			$	239,699
Income (loss) from operations	(136,646)		(4,328)		(88,880)		(23,684)			(253,538)
Interest expense										(35,773)
Other										(239)
Loss before provision for income taxes and share of net income from joint venture										$	(289,550)
Six Months Ended June 30, 2019
Net sales	$	177,340	$	157,519	$	101,050	$	(987)	(a)	$	434,922
Income (loss) from operations	13,151		6,695		9,506		(22,157)			$	7,195
Interest expense										(27,759)
Other										(3,485)
Loss before benefit for income taxes and share of net income from joint venture										$	(24,049)

_______________________________

(a)Includes elimination of intersegment transactions occurring during the ordinary course of business.

The following table presents total assets by reportable segment as of June 30, 2020, and December 31, 2019.

	Total Assets
	June 30, 2020		December 31, 2019
Life Sciences	$	637,927	$	811,526
Mobile Solutions	356,237		373,256
Power Solutions	201,781		310,545
Corporate and Consolidations	100,069		46,657
Total	$	1,296,014	$	1,541,984